Neuroblastoma is a relatively common cancer affecting infants and young babies. Research into this disease is essential to develop accurate diagnostic and screening methods to diagnose the condition ...

Proton beam therapy induced survival outcomes that were equal to or better than photon radiotherapy, and may represent a viable treatment option for some patients with pediatric neuroblastoma.

Despite improvements in cancer therapies in the past 50 years, neuroblastoma remains a devastating clinical problem and a leading cause of childhood cancer deaths. Advances in treatments for children ...

Neuroblastoma is a childhood cancer, most commonly affecting children aged between 2 -3 and can be fatal. Since the tumor cells resemble certain cells in the adrenal glands, a joint research group ...

Childhood neuroblastoma is often a fatal disease. Despite initial treatment success, most patients relapse or develop resistance to the current therapies. A new approach using a combination of two ...

Scientists have discovered gene mutations that are the main cause of the inherited (familial) version of the childhood cancer neuroblastoma. In addition, the researchers found that the same mutations ...

Neuroblastoma is a complex disease with many contradictions and challenges. It is, by and large, a cancer of babies and preschool children, but it does occur, albeit increasingly rarely, in older ...

Treatment for high-risk forms of neuroblastoma is effective but can cause serious complications. MSK researchers are investigating using a lower radiation dose to treat this cancer, which occurs in ...

Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In a promising development, researchers at Baylor College of ...

For many decades, neuroblastoma has remained a challenging disease for both clinicians and researchers. Now, techniques that efficiently specify both comprehensive genetic and gene-expression ...

An 18-year survivor of neuroblastoma, a solid childhood tumor that develops in immature nerve cells, is believed to represent the longest reported remission to date in a patient treated with chimeric ...